Attention DifficultiesNCT06114017
Effect of a Week-long Social Media Abstention on Sustained Attention Functions
A study testing Social Media Abstention in people with Attention Difficulties, run by New York Institute of Technology at 1 site in United States.
Trial summary
The current study's goal is to determine if a one-week break from social media in all forms has a beneficial effect on people's attention, as measured by the Sustained Attention to Response Task, executive function as measured by the Stroop test, and well-being. Read more about this study
- Who is it for?
- Ages 18 to 30 yearsHealthy volunteers can take part
- Conditions the study is for
- Attention Difficulties
- What is being tested?
- Social Media Abstention
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 50 participants
- Where
- 1 siteUnited States
- Study dates
- 29 Aug 2023to 31 Aug 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 30 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- 18-30 years old
- have and regularly use some form of social media
- use on average more than 1 hour of social media a day
- are willing to temporarily delete all social media for 1 week duration
Who cannot join
- no social media usage
- ADHD or other known conditions that affect attention and/or concentration
- current concussion
Trial locations and contacts
1 site in 1 country.
United States1 site, 1 recruiting
- Recruiting
NYIT
Old Westbury, New York, 11568
Amber Sousa, PhD, 631-686-7698, asousa@nyit.edu
About this study
The current study's goal is to determine if a one-week break from social media in all forms has a beneficial effect on people's attention, as measured by the Sustained Attention to Response Task, executive function as measured by the Stroop test, and well-being.
Read the detailed description
50 participants between the ages of 18 and 30 years will be recruited for the study via fliers and word of mouth. Following consent procedures, those who choose to participate will be randomized to intervention or control. 25 will be randomly selected to be in the social media group and the other 25 will be selected to go 1 week without engaging with or viewing social media to the best of their ability.
All participants will complete a demographic form at baseline and a survey about their use of social media, as well as the Bergen Social Media Assessment Scale, and the Warwick-Edinburgh Mental Wellbeing Scale. Following that, they will complete the Stroop and the SART, described below. All 50 of them will be asked to take the SART and Stroop (Inquisit Millisecond versions) tests to obtain baseline attention and executive functioning measures. Temporary deletion of social media apps will be supervised by an investigator. Subjects will be given a daily brief report/log to record any use of social media through Redcap. At the end of the week a repeat SART, Stroop, and Warwick-Edinburgh Mental Wellbeing scale will be re-administered. The group that deleted their social media will then be able to redownload their social media if they so choose. A survey about their subjective experience at the conclusion of the week will then be given to all subjects.
- Conditions
- Attention Difficulties
- Being tested
- Social Media Abstention
- Keywords
- social media, attention, wellbeing
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Social Media AbstentionBehavioural
People will stop or reduce their social media use for one week.
| Study group | Role | What they receive |
|---|---|---|
| 1: Social Media Abstention | Experimental | People in this arm will be encouraged to disable social media and not use social media for one week. Receives: Behavioral: Social Media Abstention |
| 2: Control | No intervention | People in this group will continue their normal behavior in regard to social media use. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Inquisit Sustained Attention to Response Task (SART)
A 6-minute computerized measure of attention.
Measured: through study completion, an average of one week
Secondary outcomes (2)
Inquisit Stroop Test
A 5-minute measure of executive functions.
Measured: through study completion, an average of one week
Warwick-Edinburgh Mental Wellbeing Scale
A self-report measure of general wellbeing
Measured: through study completion, an average of one week
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted2 Nov 2023
- Study start29 Aug 2023
- Primary completion31 Aug 2024 (estimated)
- Study completion31 Aug 2024 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Attention DifficultiesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Single group
- Model description
- Randomized experimental and control group
- Masking
- None (open label)
- Enrolment
- 50 participants (estimated)
Sponsor and investigators
- Lead sponsor
- New York Institute of Technology
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Amber Sousa, New York Institute of Technology
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06114017
- Sponsor's protocol ID
- BHS-1894
- Status last verified
- Apr 2024
- First submitted
- 24 Jul 2023
- Last updated
- 5 Apr 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 5 Apr 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effect of a Week-long Social Media Abstention on Sustained Attention Functions
- ClinicalTrials.gov ID
- NCT06114017
- Acronym / sponsor ID
- BHS-1894
- Conditions
- Attention Difficulties
- Keywords
- social media, attention, wellbeing
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 50 participants (estimated)
- Lead sponsor
- New York Institute of TechnologyUniversity, hospital or other
- Study start
- 29 Aug 2023 (actual)
- Primary completion
- 31 Aug 2024 (estimated)
- Study completion
- 31 Aug 2024 (estimated)
- First posted
- 2 Nov 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The current study's goal is to determine if a one-week break from social media in all forms has a beneficial effect on people's attention, as measured by the Sustained Attention to Response Task, executive function as measured by the Stroop test, and well-being.
Detailed description
50 participants between the ages of 18 and 30 years will be recruited for the study via fliers and word of mouth. Following consent procedures, those who choose to participate will be randomized to intervention or control. 25 will be randomly selected to be in the social media group and the other 25 will be selected to go 1 week without engaging with or viewing social media to the best of their ability.
All participants will complete a demographic form at baseline and a survey about their use of social media, as well as the Bergen Social Media Assessment Scale, and the Warwick-Edinburgh Mental Wellbeing Scale. Following that, they will complete the Stroop and the SART, described below. All 50 of them will be asked to take the SART and Stroop (Inquisit Millisecond versions) tests to obtain baseline attention and executive functioning measures. Temporary deletion of social media apps will be supervised by an investigator. Subjects will be given a daily brief report/log to record any use of social media through Redcap. At the end of the week a repeat SART, Stroop, and Warwick-Edinburgh Mental Wellbeing scale will be re-administered. The group that deleted their social media will then be able to redownload their social media if they so choose. A survey about their subjective experience at the conclusion of the week will then be given to all subjects.
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- Randomized experimental and control group
| Arm | Type | Receives |
|---|---|---|
| 1: Social Media Abstention | Experimental | Behavioral: Social Media AbstentionPeople in this arm will be encouraged to disable social media and not use social media for one week. |
| 2: Control | No intervention | –People in this group will continue their normal behavior in regard to social media use. |
Who may qualify
- Ages
- 18 to 30 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (4 listed)
- 18-30 years old
- have and regularly use some form of social media
- use on average more than 1 hour of social media a day
- are willing to temporarily delete all social media for 1 week duration
Key exclusion criteria (3 listed)
- no social media usage
- ADHD or other known conditions that affect attention and/or concentration
- current concussion
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Social Media AbstentionPeople will stop or reduce their social media use for one week. | Behavioural | 1: Social Media Abstention |
Primary outcome
Inquisit Sustained Attention to Response Task (SART)
Time frame: through study completion, an average of one week
A 6-minute computerized measure of attention.
2 secondary outcomes
Inquisit Stroop Test
Time frame: through study completion, an average of one week
Warwick-Edinburgh Mental Wellbeing Scale
Time frame: through study completion, an average of one week
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 5 Apr 2024.
- Individual participant dataSharing planned: No
Related trials for Attention Difficulties
Active, not recruiting
A Clinical Trial to Evaluate the Effects of a Supplement on Children's Focus and Energy
Difficulty Focusing, Poor Concentration
Recruiting
Neurocognitive Effects of Non-Invasive Near-Infrared Light Stimulation
Attention Deficit Hyperactivity Disorder, Attention Difficulties
Enrolling by invitationObservational study
Danish Access to Support and Help (DASH): Increasing Access to an Evidence-based Intervention for Children With ADHD and Their Parents
ADHD - Attention Deficit Disorder With Hyperactivity, Attention Concentration Difficulty
Recruiting
Dual Executive Function Training Package
ADHD, Dyslexia
Recruiting
Remotely Supervised tDCS+ for Complex Attention in mTBI (Cognetric)
Brain Concussion, Brain Trauma
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Social Media Abstention in people with Attention Difficulties, run by New York Institute of Technology at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 5 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Amber Sousa, PhD (516-686-7698, asousa@nyit.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Inquisit Sustained Attention to Response Task (SART) (time frame: through study completion, an average of one week). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Apr 2024.